SCHEMBL28983485

SCHEMBL28983485

CC(C)(C)OC(=O)N1CCC(Oc2cc(C(=O)O)c(N)cc2OC2CC2)CC1

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 12/20 0.50
▸ KDM1A O60341 1/20 0.50
▸ PDE4B Q07343 3/20 0.48
▸ PDE4D Q08499 3/20 0.48
▸ PDE4A P27815 2/20 0.48
▸ PDE4C Q08493 2/20 0.48
▸ TOP2A P11388 1/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ USP2 O75604 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1446669 0.91 KDM1A (0.48) GPR119KDM1APDE4BPDE4DPDE4A
SCHEMBL15363254 0.90 KDM1A (0.48) GPR119KDM1APDE4BPDE4DPDE4A
SCHEMBL28983512 0.90 KDM1A (0.48) GPR119KDM1APDE4BPDE4DPDE4A
SCHEMBL28983500 0.88 GPR119 (0.46) GPR119KDM1APDE4BPDE4DPDE4A
SCHEMBL26114272 0.87 PDE4B (0.46) GPR119KDM1APDE4BPDE4DPDE4A
SCHEMBL21612813 0.83 PDE4D (0.49) GPR119KDM1APDE4BPDE4DPDE4A
SCHEMBL1446380 0.83 GPR119 (0.55) GPR119KDM1APDE4BPDE4DPDE4A
SCHEMBL28983495 0.82 GPR119 (0.49) GPR119KDM1APDE4BPDE4DPDE4A
SCHEMBL23355410 0.80 PDE4B (0.46) GPR119KDM1APDE4BPDE4DPDE4A
SCHEMBL5098530 0.80 KDM1A (0.55) GPR119KDM1APDE4BPDE4DPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115803326-B EGFR inhibitor, preparation method thereof and application thereof in pharmacy 上海和誉生物医药科技有限公司 2024-03-26 — — CN disclosed
CN-115803326-A EGFR inhibitor, preparation method and pharmaceutical application thereof 上海和誉生物医药科技有限公司 2023-03-14 — — CN disclosed
WO-2022105908-A1 EGFR INHIBITOR, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF 上海和誉生物医药科技有限公司 2022-05-27 — — WO disclosed
Send feedback